References
- Socialstyrelsen. Cancer i siffror; 2013. Available from: https://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19108/2013-6-5.pdf
- Yang P. Epidemiology of lung cancer prognosis: quantity and quality of life. Methods Mol Biol. 2009;471:469–486.
- Yancik R, Ganz PA, Varricchio CG, et al. Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. J Clin Oncol. 2001;19:1147–1151.
- Läkemedelsverket. Lungcancer: Läkemedelsboken; 2015. Available from: http://www.lakemedelsboken.se/kapitel/onkologi/lungcancer.html
- Iachina M, Green A, Jakobsen E. The direct and indirect impact of comorbidity on the survival of patients with non-small cell lung cancer: a combination of survival, staging and resection models with missing measurements in covariates. BMJ Open. 2014;4:e003846.
- Piccirillo JF, Tierney RM, Costas I, et al. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291:2441–2447.
- Kravchenko J, Berry M, Arbeev K, et al. Cardiovascular comorbidities and survival of lung cancer patients: medicare data based analysis. Lung Cancer. 2015;88:85–93.
- Bernard A, Rivera C, Pages PB, et al. Risk model of in-hospital mortality after pulmonary resection for cancer: a national database of the French Society of Thoracic and Cardiovascular Surgery (Epithor). J Thorac Cardiovasc Surg. 2011;141:449–458.
- Luchtenborg M, Jakobsen E, Krasnik M, et al. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients. Eur J Cancer. 2012;48:3386–3395.
- Jakobsen E, Rasmussen TR, Green A. Mortality and survival of lung cancer in Denmark: results from the Danish Lung Cancer Group 2000–2012. Acta Oncol. 2016;55(Suppl 2):2–9.
- Battafarano RJ, Piccirillo JF, Meyers BF, et al. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002;123:280–287.
- Moro-Sibilot D, Aubert A, Diab S, et al. Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer. Eur Respir J. 2005;26:480–486.
- Smith SL, Palma D, Parhar T, et al. Inoperable early stage non-small cell lung cancer: comorbidity, patterns of care and survival. Lung Cancer (Amsterdam, Netherlands). 2011;72:39–44.
- Asmis TR, Ding K, Seymour L, et al. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. JCO. 2008;26:54–59.
- Gronberg BH, Sundstrom S, Kaasa S, et al. Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. Eur J Cancer. 2010;46:2225–2234.
- Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48:27–33.
- Young J, Badgery-Parker T, Dobbins T, et al. Comparison of ECOG/WHO performance status and ASA score as a measure of functional status. J Pain Symptom Manage. 2015;49:258–264.
- Longitudinal integration database for health insurence and labour market studies (LISA) 1990–2009. Statistics Sweden, Stockholm, Sweden, 2011. 2011;[art. nr. AM76BR1104].
- Socialstyrelsen. Statistik om Dödsorsaker 2015. Available from: http://www.socialstyrelsen.se/SiteCollectionDocuments/2016-8-3-beskrivning-av-statistiken.pdf
- Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–682.
- Huang YGR, Diao Y. Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy. J Zhejiang Univ Sci B. 2014;15:58–66.
- R Foundation for Statistical Computing V, Austria. R Core Team. R: A language and environment for statistical computing 2014. Available from: http://www.R-project.org/
- Lu JT, Creager MA, The relationship of cigarette smoking to peripheral arterial disease. Reviews in cardiovascular medicine. 2004;5:189–193.
- Pelkonen M. Smoking: relationship to chronic bronchitis, chronic obstructive pulmonary disease and mortality. Curr Opin Pulmon Med. 2008;14:105–109.
- Mahonen M, McElduff P, Kuulasmaa K, et al. Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA Project populations. Tob Control. 2004;13:244–250.
- Centre RC, National guidelines of lung cancer 2015. Available from: http://www.cancercentrum.se/samverkan/cancerdiagnoser/lunga-och-lungsack/vardprogram/gallande-vardprogram/11.-kirurgisk-behandling/
- Janssen-Heijnen MSS. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax. 2004;59:602–607.
- de Rijke JM, Schouten LJ, ten Velde GPM, et al. Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study. Lung Cancer (Amsterdam, Netherlands). 2004;46:233–245.
- Freeman RK, Ascioti AJ, Dake M, et al. The effects of a multidisciplinary care conference on the quality and cost of care for lung cancer patients. Ann Thorac Surg. 2015;100:1834–1838. discussion 8.
- Welfare NBoHa [Internet]. Dödsorsaksregistret 2009 (Cause of Death). 2011. Available from: http://www.scb.se/Statistik/HS/HS0301/_dokument/HS0301_BS_2009.pdf
- Otake S, Ohtsuka T, Asakura K, et al. Impact of comorbidity index on morbidity and survival in non-small cell lung cancer. Asian Cardiovasc Thorac Ann. 2016;24:30–33.
- Welfare NBoHa. National Patient Register 2016. Available from: http://www.socialstyrelsen.se/register/halsodataregister/patientregistret/inenglish